Myogrel Tablets: Clopidogrel Anti-Platelet Medication
Composition:
Each tablet contains: Clopidogrel 75 mg
Properties:
Clopidogrel is an anti-platelet drug that acts by inhibiting adenosine diphosphate-mediated platelet aggregation.
Indications:
- Prophylactically as an alternative to aspirin in patients at risk of thrombotic events as with recent myocardial infarction, unstable angina, recent stroke, and peripheral arterial disease.
- It is also used as an adjunct to aspirin for the prevention of sub-acute stent occlusion after intracoronary stenting.
Dosage Administration:
One 75 mg tablet with or without food regularly and at the same time each day. Not intended for children or adolescents below the age of 18 years.
Contra Indications:
- Patients with hematopoietic disorders such as Neutrogena or thrombocytopenia or other hemorrhagic disorders associated with a prolonged bleeding time.
- Conditions with an increased risk of bleeding such as gastrointestinal ulcers, acute cerebral hemorrhage, or severe liver dysfunction.
- It is contraindicated also with breastfeeding.
Precautions and Warnings:
- Recent serious injury.
- Blood disorder that may lead to internal bleeding.
- Surgery (including dental) within a period of two weeks.
- Kidney or liver disease.
Side Effects:
Gastrointestinal disturbances and skin rashes are the most commonly reported side effects associated.
Packing:
Box contains 30 tablets in 3 strips.
Myogrel is a product manufactured by Adwia Pharmaceuticals Industries. Adwia is a leading Egyptian company founded in 1984 with a mission to bring the latest technologies and the highest available know-how to the market. They are committed to innovation and care and have a proven track record of success. For more information about Adwia Pharmaceuticals Industries, please visit their website or contact them directly.
Comments
Post a Comment